Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 5411-5420 Newer>

The Motley Fool February 3, 2009 Robert Steyer	An Emerging Medical Power Take a look at a company whose stock price has quintupled over the past five years: Australia-based pharmaceutical CSL. And this could be just the beginning of great things to come.
The Motley Fool February 3, 2009 Andy Louis-Charles	The Biggest Idea in Health Care Part two of our interview with Princeton University's Prof. Uwe Reinhardt on health-care economics.
The Motley Fool February 3, 2009 Andy Louis-Charles	Can Health Care Heal Our Ailing Economy? Part one of our interview with Princeton University's Prof. Uwe Reinhardt on health-care economics.
Reason February 2009 Ronald Bailey	I Want a New Drug States that adopted new drugs more rapidly, had the smallest increases in disability rates.
Reason February 2009 Ronald Bailey	E.R. Crowding A study blames a rising population, a falling number of emergency departments, and understaffing that prevents stabilized patients from being admitted to other parts of the hospital.
Reason February 2009 Cheryl Miller	Who's Your Daddy? Children of sperm donors are seeking more information about their once-anonymous fathers, sometimes at the risk of the fertility industry itself.
The Motley Fool January 30, 2009 Brian Orelli	Mark Your Calendars: The Race Is On! In the last couple of weeks, both Schering-Plough and Vertex Pharmaceuticals have announced that their phase 3 hepatitis C drugs trials have finished enrolling patients.
The Motley Fool January 30, 2009 Brian Orelli	Icahn's Next Target Activist investor Carl Icahn has decided to nominate a slate of five directors for the board of Amylin Pharmaceuticals, of which he owns 8.3%.
The Motley Fool January 30, 2009 Brian Orelli	Celgene's Double Take Still Looks Good No one is going to stop using Celgene's cancer-fighting products just because the economy is in the tank, so the company should have no problem hitting or even exceeding its growth estimates the way it has before.
The Motley Fool January 30, 2009 Brian Orelli	Sequenom Is a Rule Breaker Sequenom has potential; it wants to become the go-to place for molecular diagnostics.
<Older 5411-5420 Newer> Return to current articles.